Form 4: Rallybio Corp Director Hopfner Acquires Options

Robert Lorne Hopfner, a director of Rallybio Corp, reports the acquisition of options to purchase 28,500 shares of common stock.

Summary

• Robert Lorne Hopfner, a director of Rallybio Corp, filed a Form 4 detailing changes in beneficial ownership.
• On May 13, 2025, Hopfner acquired options to purchase 28,500 shares of Rallybio Corp common stock at an exercise price of $0.30.
• The options were granted under the company's 2021 Equity Incentive Plan and vest on the earlier of May 13, 2026, or the date of the company's 2026 Annual Meeting of Stockholders.
• Following the transaction, Hopfner directly owns options for 28,500 shares.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The sentiment is neither positive nor negative.

Positives

• The acquisition of options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• Shareholders may view the director's option acquisition as a sign of confidence in the company.

Key Dates

Keywords

Form 4, beneficial ownership, options, Rallybio Corp, RLYB, Hopfner, director, equity incentive plan